|
RNA-sequencing and bioinformatic analysis to pre-assess sensitivity to targeted therapeutics in recurrent glioblastoma. |
| |
|
Employment - Ortho Centrum Hamburg (I) |
| |
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |
| |
|
No Relationships to Disclose |
| |
|
|
|
Stock and Other Ownership Interests - Vitamed |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Brainlab; Mazor Robotics; RTI Health Solutions; Stryker; Zimmer Biomet |
Patents, Royalties, Other Intellectual Property - Patent on spinal dynamic stabilization device (Inst) |
Travel, Accommodations, Expenses - RTI Health Solutions; Stryker; Zimmer Biomet |
| |
|
Patents, Royalties, Other Intellectual Property - Patent on spinal dynamic stabilization device (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Ortho Centrum Hamburg |
Patents, Royalties, Other Intellectual Property - Patents on medical devices (Inst) |